Standout Papers
Citation Impact
Citing Papers
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Transplant tolerance through costimulation blockade - are we there yet?
2007
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
ENTPD1/CD39 is a promising therapeutic target in oncology
2012
Cytokines in inflammatory bowel disease
2014 Standout
Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health
2014
New insights into T cell biology and T cell‐directed therapy for autoimmunity, inflammation, and immunosuppression
2010
Delayed graft function in kidney transplantation
2004 Standout
Advancing islet transplantation: from engraftment to the immune response
2011
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
2000 Standout
Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection
2017 StandoutNobel
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
2008 Standout
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Hypertension after renal transplantation
2007
Cytokines in cancer immunity and immunotherapy
2004
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Improving de novo protein binder design with deep learning
2023 StandoutNobel
SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
1999 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Tissue viral load variability in chronic hepatitis C
2001
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
2015
Structural basis of immunosuppression by the therapeutic antibody daclizumab
2010
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
2005 Standout
Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function
2009
Tolerance, Danger, and the Extended Family
1994 Standout
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens
2001
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
2006
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
T cell–directed therapies: lessons learned and future prospects
2006
Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
2002
The Natural History of Chronic Allograft Nephropathy
2003 Standout
Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy
2002
Comparison of Baseline Characteristics, Management and Outcome of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome in Versus Not in Clinical Trials
2010
Does subclinical rejection contribute to chronic rejection in renal transplant patients?
1999
T-Cell Costimulatory Pathways in Allograft Rejection and Tolerance
2005
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
2006 Standout
Type 1 diabetes
2013 Standout
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
The immunologic basis for the treatment of psoriasis with new biologic agents
2002
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Clinical application of sirolimus in renal transplantation: an update
2005
Chronic Lung Allograft Rejection: Mechanisms and Therapy
2009
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Cytokines in Cancer Immunotherapy
2017
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 Standout
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
MULTICENTER TRIAL EXPLORING CALCINEURIN INHIBITORS AVOIDANCE IN RENAL TRANSPLANTATION
2001
Infection in Solid-Organ Transplant Recipients
2007 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Immunosuppressive strategies in transplantation
1999
The therapeutic potential of carbon monoxide
2010 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
A PROSPECTIVE, RANDOMIZED TRIAL OF TACROLIMUS/PREDNISONE VERSUS TACROLIMUS/PREDNISONE/MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS*
1999
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
The many masks of focal segmental glomerulosclerosis
1994
Update on Islet Transplantation
2012
Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study
2007
Cell Biology of the Glomerular Podocyte
2003 Standout
Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
2012 StandoutNobel
A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis
2003
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
THE MULTIFACETED REGULATION OF INTERLEUKIN-15 EXPRESSION AND THE ROLE OF THIS CYTOKINE IN NK CELL DIFFERENTIATION AND HOST RESPONSE TO INTRACELLULAR PATHOGENS
1999
Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
2010
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial
2006
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes
2001
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
The Yin and Yang of regulatory T cells in infectious diseases and avenues to target them
2017
The Influence of Allogeneic Cells on the Human T and B Cell Repertoire
1990 Science
Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol
2001 Standout
Works of F. Vincenti being referenced
Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection.
1995
Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody Efalizumab
2010
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis
2000
Living Donor Kidney Transplant Recipients and Clinical Trials: Participation Profiles and Impact on Post-Transplant Care
2006
Recurrent focal glomerulosclerosis: Natural history and response to therapy
1992
Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients
2009
Sotrastaurin, a Novel Small Molecule Inhibiting Protein-Kinase C: Randomized Phase II Study in Renal Transplant Recipients
2011
New monoclonal antibodies in renal transplantation.
2003
Improved graft survival with donor-specific transfusion pretreatment.
1981
PRELIMINARY RESULTS OF THE COMBINED USE OF A HUMANIZED ANTI-IL-2Rα MONOCLONAL ANTIBODY, DACLIZUMAB (DZB), AND MYCOPHENOLATE MOFETIL (MMF) WITHOUT CALCINEURIN INHIBITORS IN RENAL TRANSPLANTATION
1998
A MULTICENTER, OPEN LABEL PILOT STUDY OF EARLY (5 DAY) CORTICOSTEROID CESSATION IN DE NOVO RENAL TRANSPLANT RECIPIENTS UNDER SIMULECT, TACROLIMUS, AND SIROLIMUS THERAPY: ONE YEAR RESULTS
2004